Lymphoma

Dear Colleagues

Malignant lymphomas represent transformations within the lymphoid system. Various subtypes with divergent biology, morphology, clinical presentation, and prognosis can be distinguished. Despite substantial recent progress in the understanding of the molecular pathogenesis of these malignancies, as well as their treatment, still a substantial fraction of affected patients cannot be cured with current therapy. Especially, patients affected by lymphomas that are refractory to conventional immunochemotherapy represent a major clinical problem. Thus, a significantly better understanding of the biology of lymphomagenesis is urgently warranted. This will enable us to incorporate novel molecular targeted therapies into the treatment of affected patients and improve their outcome. This special issue focuses on novel advances in the understanding of the molecular mechanisms leading to lymphoma development, as well as on the development of novel therapeutic regimens to improve prognosis of affected patients.

Prof. Dr. Georg Lenz
Prof. Dr. Martin Dreyling
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.